Compare · CVII vs ORIA
CVII vs ORIA
Side-by-side comparison of Churchill Capital Corp VII (CVII) and Orion Biotech Opportunities Corp. (ORIA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CVII and ORIA operate in Blank Checks (Finance), so they compete in similar markets.
- CVII is the larger of the two at $1.68B, about 6.9x ORIA ($242.0M).
Churchill Capital Corp VII
Churchill Capital Corp VII focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
Orion Biotech Opportunities Corp.
Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.
Latest CVII
- Amendment: SEC Form SC 13G/A filed by Churchill Capital Corp VII
- SEC Form 15-12G filed by Churchill Capital Corp VII
- Large owner Magnetar Financial Llc disposed of $90,084,438 worth of shares (8,306,005 units at $10.85) (SEC Form 4)
- Churchill Capital Corp VII filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- SEC Form 25-NSE filed by Churchill Capital Corp VII
- Churchill Capital Corp VII and CorpAcq Mutually Agree to Terminate Business Combination
- SEC Form 10-Q filed by Churchill Capital Corp VII
- Churchill Capital Corp VII filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form DEFA14A filed by Churchill Capital Corp VII
- SEC Form DEFA14A filed by Churchill Capital Corp VII
Latest ORIA
- SEC Form SC 13G/A filed by Orion Biotech Opportunities Corp. (Amendment)
- SEC Form 4 filed by Collins James J.
- SEC Form 4 filed by Broder Samuel
- SEC Form 4 filed by Orion Sponsor Holdings, Llc
- SEC Form 4 filed by Rodriguez Louisa
- SEC Form 15-12G filed by Orion Biotech Opportunities Corp.
- SEC Form 25 filed by Orion Biotech Opportunities Corp.
- Orion Biotech Opportunities Says Will Redeem Public Share, Will Not Consummate Initial Business Combination
- Orion Biotech Opportunities Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 10-K filed by Orion Biotech Opportunities Corp.